0001824034-24-000003.txt : 20240716
0001824034-24-000003.hdr.sgml : 20240716
20240716131946
ACCESSION NUMBER: 0001824034-24-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240716
DATE AS OF CHANGE: 20240716
EFFECTIVENESS DATE: 20240716
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avicenna Biosciences, Inc.
CENTRAL INDEX KEY: 0001824034
ORGANIZATION NAME:
IRS NUMBER: 851962440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-518896
FILM NUMBER: 241119246
BUSINESS ADDRESS:
STREET 1: 101 W. CHAPEL HILL STREET, SUITE 210
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-667-2504
MAIL ADDRESS:
STREET 1: 101 W. CHAPEL HILL STREET, SUITE 210
CITY: DURHAM
STATE: NC
ZIP: 27701
D
1
primary_doc.xml
X0708
D
LIVE
0001824034
Avicenna Biosciences, Inc.
101 W. Chapel Hill Street
Suite 210
DURHAM
NC
NORTH CAROLINA
27701
919-667-2504
DELAWARE
None
None
Corporation
true
2020
Christopher
Meldrum
c/o Avicenna Biosciences, Inc.
101 W. Chapel Hill Street, Suite 210
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Director
Thomas
Kaiser
c/o Avicenna Biosciences, Inc.
101 W. Chapel Hill Street, Suite 210
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Director
Pieter
Burger
c/o Avicenna Biosciences, Inc.
101 W. Chapel Hill Street, Suite 210
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Director
John
Hamer
c/o Avicenna Biosciences, Inc.
101 W. Chapel Hill Street, Suite 210
Durham
NC
NORTH CAROLINA
27701
Director
Dennis
Langer
c/o Avicenna Biosciences, Inc.
101 W. Chapel Hill Street, Suite 210
Durham
NC
NORTH CAROLINA
27701
Director
Biotechnology
Decline to Disclose
- 06b
false
2024-07-01
false
true
false
0
6000000
6000000
0
false
1
0
0
0
Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
false
Avicenna Biosciences, Inc.
/s/ Christopher Meldrum
Christopher Meldrum
President
2024-07-16